Leiping Wang

2.3k total citations · 1 hit paper
81 papers, 1.4k citations indexed

About

Leiping Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Leiping Wang has authored 81 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 24 papers in Cancer Research. Recurrent topics in Leiping Wang's work include Cancer Treatment and Pharmacology (34 papers), HER2/EGFR in Cancer Research (30 papers) and Advanced Breast Cancer Therapies (21 papers). Leiping Wang is often cited by papers focused on Cancer Treatment and Pharmacology (34 papers), HER2/EGFR in Cancer Research (30 papers) and Advanced Breast Cancer Therapies (21 papers). Leiping Wang collaborates with scholars based in China, Canada and United States. Leiping Wang's co-authors include Biyun Wang, Jun Cao, Xichun Hu, Jian Zhang, Zhonghua Tao, Zhonghua Wang, Xiaorong Dai, Zhimin Shao, Dezhao Liu and Zhonghua Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Leiping Wang

76 papers receiving 1.4k citations

Hit Papers

Breast cancer: pathogenesis and treatments 2025 2026 2025 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leiping Wang China 20 576 460 313 285 138 81 1.4k
Xiangxiang Zhou China 25 465 0.8× 1.1k 2.3× 181 0.6× 335 1.2× 140 1.0× 124 2.1k
Norio Kubo Japan 23 673 1.2× 568 1.2× 260 0.8× 314 1.1× 113 0.8× 143 1.9k
Jie Mei China 26 403 0.7× 1.0k 2.3× 393 1.3× 646 2.3× 183 1.3× 127 2.0k
Xiaozhong Chen China 23 312 0.5× 347 0.8× 294 0.9× 131 0.5× 106 0.8× 117 1.4k
Xiaoyu Yin China 27 759 1.3× 824 1.8× 361 1.2× 533 1.9× 233 1.7× 133 2.9k
Min-Jung Kim South Korea 18 289 0.5× 453 1.0× 80 0.3× 227 0.8× 127 0.9× 28 988
Zhan Wang China 18 326 0.6× 287 0.6× 271 0.9× 145 0.5× 117 0.8× 129 1.3k
Jiahua Zhou China 24 363 0.6× 510 1.1× 114 0.4× 341 1.2× 209 1.5× 77 1.6k
Tingting Zhong China 19 221 0.4× 394 0.9× 98 0.3× 201 0.7× 70 0.5× 82 1.1k

Countries citing papers authored by Leiping Wang

Since Specialization
Citations

This map shows the geographic impact of Leiping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leiping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leiping Wang more than expected).

Fields of papers citing papers by Leiping Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leiping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leiping Wang. The network helps show where Leiping Wang may publish in the future.

Co-authorship network of co-authors of Leiping Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Leiping Wang. A scholar is included among the top collaborators of Leiping Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leiping Wang. Leiping Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Leiping, et al.. (2025). Deep CO2 photoreduction by synergy of K+ doping and defective modulation over TiO2@K2Ti6O13 nanoribbon heterojunctions. Journal of environmental chemical engineering. 13(4). 117221–117221. 1 indexed citations
2.
Jin, Juan, Tiantian Liu, Mingchuan Zhao, et al.. (2025). Clinical and genomic characteristics of HER2-ultralow breast cancer and implications for T-DXd therapy. Precision Clinical Medicine. 8(4). pbaf026–pbaf026.
3.
Wang, Leiping, Yang Meng, Wei Wang, et al.. (2025). Boosting photocatalytic desulfurization efficiency via in-situ Ti-MOF disassembly and reconstruction strategies on S-scheme M-TiO2@Cu2S heterojunction. Chemical Engineering Journal. 514. 163283–163283. 2 indexed citations
4.
Hu, Xichun, Leiping Wang, Jian Zhang, et al.. (2024). ACE-Breast-02: A pivotal phase II/III trial of ARX788, a novel anti-HER2 antibody-drug conjugate (ADC), versus lapatinib plus capecitabine for HER2+ advanced breast cancer (ABC).. Journal of Clinical Oncology. 42(16_suppl). 1020–1020. 7 indexed citations
5.
Dai, Xiaorong, Leiping Wang, Yuxuan He, et al.. (2024). In situ synthesis of porous metal-organic frameworks NH2-UiO-66 on tea stem biochar and application in odours adsorption. Environmental Pollution. 353. 124168–124168. 6 indexed citations
6.
Wang, Leiping, Ding‐Ming Xue, Lei Tong, et al.. (2024). Insights into the Effect of Crystal Facets and Sulfur Defects on the Product Selectivity of Various CdS Configurations for CO2 Photoreduction: A DFT Study. Catalysts. 14(10). 688–688. 2 indexed citations
7.
Wang, Leiping, Xiaorong Dai, Kaiying Wang, et al.. (2024). Graphene-decorated novel Z-scheme Bi@MOF composites promote high performance photocatalytic desulfurization. Chemical Engineering Journal. 485. 149977–149977. 20 indexed citations
8.
Zhang, Chengchen, Xiaorong Dai, Yuan Wang, et al.. (2024). Navigating the Aerosolized Frontier: A Comprehensive Review of Bioaerosol Research Post-COVID-19. Atmosphere. 15(4). 404–404. 6 indexed citations
9.
Jin, Juan, Bin Li, Ting Li, et al.. (2023). Analysis of clinical features, genomic landscapes and survival outcomes in HER2-low breast cancer. Journal of Translational Medicine. 21(1). 360–360. 18 indexed citations
10.
Wu, Kun, Junyi Zhao, Jun He, et al.. (2022). Promotional effects of calcination temperature and H2O on the catalytic activity of Al-substituted MnAlO catalysts for low-temperature acetone oxidation. Chemosphere. 301. 134722–134722. 13 indexed citations
11.
Zhang, Jian, Yanchun Meng, Biyun Wang, et al.. (2022). Dalpiciclib Combined With Pyrotinib and Letrozole in Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer (LORDSHIPS): A Phase Ib Study. Frontiers in Oncology. 12. 775081–775081. 11 indexed citations
13.
Meng, Yanchun, Hao Tang, Zhiguo Luo, et al.. (2021). An integrated bioinformatics analysis to investigate the targets of miR-133a-1 in breast cancer. Translational Cancer Research. 10(3). 1238–1248. 2 indexed citations
14.
Wang, Leiping, et al.. (2020). PDGFD induces ibrutinib resistance of diffuse large B‑cell lymphoma through activation of EGFR. Molecular Medicine Reports. 21(5). 2209–2219. 10 indexed citations
15.
Lin, Ying, Mingxi Lin, Jian Zhang, et al.. (2020). Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis. Cancer Research and Treatment. 52(4). 1059–1066. 34 indexed citations
17.
Li, Ting, Biyun Wang, Zhonghua Wang, et al.. (2015). Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial. PLoS ONE. 10(7). e0133133–e0133133. 6 indexed citations
18.
Wang, Leiping, et al.. (2014). Risk factors of post-traumatic hydrocephalus after decompressive craniectomy for patients with craniocerebral trauma. Zhonghua chuangshang zazhi. 30(4). 307–310. 3 indexed citations
19.
YouSheng, Liang, Jia-Gang Guo, Leiping Wang, et al.. (2009). Establishment and applying for the national appraisal system of materials of health education for schistosomiasis control.. 21(1). 43–46. 1 indexed citations
20.
Wang, Leiping, et al.. (2007). Sustainable Energy in China : The Closing Window of Opportunity. RePEc: Research Papers in Economics. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026